Annual report pursuant to Section 13 and 15(d)

License Agreement (Details Narrative)

v3.21.2
License Agreement (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 12 Months Ended
May 11, 2021
May 31, 2021
May 31, 2020
Jun. 30, 2020
Jun. 30, 2021
Research and development expense       $ 150,000 $ 2,269,998
IPO [Member]          
Number of shares of common stock 3,078,224        
Vernalis Development Limited [Member]          
Research and development expense     $ 150,000   $ 1,350,000
Development milestone payment     29,900,000    
Vernalis Development Limited [Member] | IPO [Member]          
Number of shares of common stock   192,857      
Future milestone payments   $ 1,350,000      
Vernalis Development Limited [Member] | Minimum [Member]          
Marketing authorization amount     350,000    
Sales milestone payments     10,000,000    
Cumulative annual net sales amount     500,000,000    
Vernalis Development Limited [Member] | Maximum [Member]          
Marketing authorization amount     3,000,000    
Sales milestone payments     25,000,000    
Cumulative annual net sales amount     $ 1,000,000,000